uniQure N.V. financial data

Symbol
QURE on Nasdaq
Industry
Pharmaceutical Preparations
Location
Paasheuvelweg 25 A, Amsterdam, Netherlands
Fiscal year end
December 31
Former names
uniQure B.V. (to 2/6/2014)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 984 % +31.4%
Quick Ratio 16.6 % +97.4%
Debt-to-equity 250 % +411%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.5 M shares +2.03%
Common Stock, Shares, Outstanding 48.5 M shares +1.99%
Entity Public Float 547 M USD -37.2%
Common Stock, Value, Issued 2.92 M USD +1.74%
Weighted Average Number of Shares Outstanding, Basic 48.4 M shares +2%
Weighted Average Number of Shares Outstanding, Diluted 48.4 M shares +2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 195 M USD -8.74%
Costs and Expenses 286 M USD +1.69%
Operating Income (Loss) -263 M USD -61.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -293 M USD -83.9%
Income Tax Expense (Benefit) 3.78 M USD
Earnings Per Share, Basic -6.2 USD/shares -85.6%
Earnings Per Share, Diluted -6.2 USD/shares -85.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 243 M USD +58%
Inventory, Net 7.67 M USD +2.61%
Assets, Current 596 M USD +34.6%
Deferred Income Tax Assets, Net 11.6 M USD -19.1%
Property, Plant and Equipment, Net 44.6 M USD -11%
Operating Lease, Right-of-Use Asset 27.7 M USD -13.8%
Intangible Assets, Net (Excluding Goodwill) 60.5 M USD +2.9%
Goodwill 25.8 M USD -0.78%
Other Assets, Noncurrent 5.3 M USD -13.4%
Assets 770 M USD +22%
Accounts Payable, Current 5.23 M USD -41.1%
Employee-related Liabilities, Current 9.57 M USD +2.37%
Accrued Liabilities, Current 22.7 M USD +0.57%
Liabilities, Current 63.5 M USD -4.32%
Deferred Income Tax Liabilities, Net 7.38 M USD +5.83%
Operating Lease, Liability, Noncurrent 27 M USD -13.2%
Other Liabilities, Noncurrent 3.32 M USD +247%
Liabilities 623 M USD +186%
Accumulated Other Comprehensive Income (Loss), Net of Tax -56 M USD -6.76%
Retained Earnings (Accumulated Deficit) -956 M USD -45%
Stockholders' Equity Attributable to Parent 147 M USD -64.4%
Liabilities and Equity 770 M USD +22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -60.6 M USD +22.6%
Net Cash Provided by (Used in) Financing Activities 363 M USD +25002%
Net Cash Provided by (Used in) Investing Activities 64 M USD +2041%
Common Stock, Shares Authorized 80 M shares 0%
Common Stock, Shares, Issued 48.5 M shares +1.99%
Common Stock, Par or Stated Value Per Share 0.05 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.69 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 246 M USD +56.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.76 M USD +55.7%
Deferred Tax Assets, Valuation Allowance 145 M USD +94.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.26 pure 0%
Deferred Tax Assets, Gross 174 M USD +65.5%
Operating Lease, Liability 36.7 M USD -8.58%
Depreciation 10.3 M USD +25.6%
Payments to Acquire Property, Plant, and Equipment 2.34 M USD +0.09%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -300 M USD -76.2%
Lessee, Operating Lease, Liability, to be Paid 49.9 M USD -13%
Property, Plant and Equipment, Gross 102 M USD +7.99%
Operating Lease, Liability, Current 8 M USD +4.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.21 M USD +8.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.37 M USD -0.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) 1.81 M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.3 M USD -23.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.33 M USD +4.74%
Deferred Tax Assets, Operating Loss Carryforwards 146 M USD +72.3%
Current Income Tax Expense (Benefit) 110 K USD +358%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.27 M USD +1.71%
Operating Lease, Payments 7.92 M USD +5.17%
Additional Paid in Capital 1.16 B USD +3.06%
Deferred Tax Assets, Net of Valuation Allowance 29 M USD -5.5%
Share-based Payment Arrangement, Expense 35.1 M USD +2.6%
Interest Expense 54.1 M USD +324%